BioTissue Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Latest Deal Type
-
Accelerator/Inc
- Financing Rounds
-
8
BioTissue General Information
Description
Provider of ortho-biological devices catering to patients and health professionals. The company offers a three-dimensional autologous chondrocyte graft to treat articular cartilage defects in the knee through guided tissue regeneration and tissue engineering, thereby providing therapies to regenerate damaged tissues or organs.
Contact Information
Website
www.biotissue.chCorporate Office
- 5, Rue Paul-Bouchet
- 1201 Geneva
- Switzerland
Corporate Office
- 5, Rue Paul-Bouchet
- 1201 Geneva
- Switzerland
BioTissue Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioTissue Comparisons
Industry
Financing
Details
BioTissue Competitors (7)
One of BioTissue’s 7 competitors is Synthecon, a Formerly Accelerator/Incubator backed company based in Houston, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Synthecon | Formerly Accelerator/Incubator backed | Houston, TX | ||||
| TearSolutions | Venture Capital-Backed | Charlottesville, VA | ||||
| ONL Therapeutics | Venture Capital-Backed | Ann Arbor, MI | ||||
| Augurex | Venture Capital-Backed | Vancouver, Canada | ||||
| Clearside Biomedical | Formerly VC-backed | Alpharetta, GA |
BioTissue Patents
BioTissue Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2940646-T3 | Set for endoscopic fixation of an implant in an intervertebral disc by means of a nail or a pin | Active | 19-Mar-2019 | ||
| ES-2957134-T3 | Set for endoscopic fixation of an implant in an intervertebral disc by means of a nail or a pin | Active | 19-Mar-2019 | ||
| EP-3833281-A1 | Set for endoscopic fixation of an implant in an intervertebral disc by means of a nail or pin | Active | 19-Mar-2019 | ||
| WO-2020187444-A1 | Set for endoscopic fixation of an implant in an intervertebral disc by means of a nail or pin | Inactive | 19-Mar-2019 | ||
| EP-3711687-A1 | Set for endoscopic fixing of an implant in an intervertebral disc with a nail or pin | Active | 19-Mar-2019 | A61B17/1757 |
BioTissue Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioTissue FAQs
-
When was BioTissue founded?
BioTissue was founded in 1997.
-
Where is BioTissue headquartered?
BioTissue is headquartered in Geneva, Switzerland.
-
What industry is BioTissue in?
BioTissue’s primary industry is Therapeutic Devices.
-
Is BioTissue a private or public company?
BioTissue is a Private company.
-
What is BioTissue’s current revenue?
The current revenue for BioTissue is .
-
How much funding has BioTissue raised over time?
BioTissue has raised $23.1M.
-
Who are BioTissue’s investors?
COI Partners, DIH Deutsche Industrie Holding, and EVP Capital Management have invested in BioTissue.
-
Who are BioTissue’s competitors?
Synthecon, TearSolutions, ONL Therapeutics, Augurex, and Clearside Biomedical are some of the 7 competitors of BioTissue.
-
When was BioTissue acquired?
BioTissue was acquired on 01-Jan-2025.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process